| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |